Prof. Conrad Falkson: The primary function of the radiation is to reduce the risk of local recurrence where complete surgical resection has not been achieved

Prof. Paul Van Schil: Complete resection is a major prognostic factor and should remain the principal aim of surgical resection

Prof. Ritsuko Komaki: Radiation therapy for thymic malignancies to improve local control, overall survival and disease free survival

Prof. Meinoshin Okumura: More studies in thymoma-associated autoimmune diseases are needed

Dr. Jeanne B. Ackman: TNM staging system has made huge progress for the diagnosis and treatment of thymic tumors

Prof. Edith Marom: ITMIG is an innovative, young society open to all from all disciplines

Prof. Chang Hyun Kang: enthusiasm is important for a successful career

ITMIG 2017—Prof. Frank Detterbeck: we are all here for the same goal

ITMIG 2017—Interview with Dr. Ugo Pastorino: open surgery or minimally invasive surgery for patients with early stage thymoma?

ITMIG 2017—Dr. Andreas Rimner: expertise, equipment, and experience are critical prerequisites in intraoperative radiotherapy

ITMIG 2017 | Prof. Nicolas Girard: cooperation network and database of thymic malignancy research

ITMIG 2017—Dr. Giuseppe Giaccone: focus on data and keep up-to-date

ITMIG 2017|Prof. Patrick Loehrer: conduct more clinical trials to get more helpful information and benefits patients